2018
DOI: 10.1016/j.jchromb.2018.01.038
|View full text |Cite
|
Sign up to set email alerts
|

Chinese patent medicine Xin-Ke-Shu inhibits Ca 2+ overload and dysfunction of fatty acid β -oxidation in rats with myocardial infarction induced by LAD ligation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 54 publications
0
7
0
Order By: Relevance
“…The proteomic analysis revealed protein alterations in NIH3T3 cells under OGD conditions, in which the upregulated differentially expressed proteins were involved in fatty acid degradation. Importantly, proteins related to the fatty acid degradation pathway in the heart have indeed been reported to be highly expressed after MI, , which is consistent with the results of this study. A KEGG pathway analysis of the differentially expressed proteins affected by TSA did not show an enrichment of the fatty acid metabolism pathway in NIH3T3 cells under OGD conditions.…”
Section: Discussionmentioning
confidence: 99%
“…The proteomic analysis revealed protein alterations in NIH3T3 cells under OGD conditions, in which the upregulated differentially expressed proteins were involved in fatty acid degradation. Importantly, proteins related to the fatty acid degradation pathway in the heart have indeed been reported to be highly expressed after MI, , which is consistent with the results of this study. A KEGG pathway analysis of the differentially expressed proteins affected by TSA did not show an enrichment of the fatty acid metabolism pathway in NIH3T3 cells under OGD conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Coronary heart disease includes a series of clinical conditions, such as myocardial infarction and arrhythmia, caused by atherosclerosis, which leads to narrowing of the coronary artery lumen and insufficient blood supply to the heart muscle (Lei et al, 2018;Liu et al, 2018). Coronary heart disease is the main cause of sudden cardiac death worldwide, accompanied by apoptosis and myocardial fibrosis, leading to HF (Yang et al, 2018a;Yang et al, 2018b).…”
Section: Coronary Heart Disease and Myocardial Infarctionmentioning
confidence: 99%
“…Xin-Ke-Shu (XKS), Guanxinshutong capsule (GXSTC), modified Yiqi decoction (MYQ), and other Chinese herbal compound preparations are involved in the regulation of calcium signaling during the treatment of coronary heart disease and myocardial infarction (Yang et al, 2018a;Liu et al, 2017b;Yu et al, 2017) (Table 5). Xin-Ke-Shu tablet (XKS) is mainly composed of Salvia miltiorrhiza, Radix Puerariae, Hawthorn, Panax Notoginseng and Radix Aucklandiae.…”
Section: Coronary Heart Disease and Myocardial Infarctionmentioning
confidence: 99%
See 1 more Smart Citation
“…Maesen & S.M.Almeida ex Sanjappa & Predeep (Gegen in Chinese), Crataegus pinnatifida Bunge (Shanzha in Chinese), Panax notoginseng (Burkill) F.H.Chen (Sanqi in Chinese), and Aucklandia costus Falc (Muxiang in Chinese), in a ratio of 15:15:15:1:1, have been extensively used for the treatment of cardiovascular diseases (CVDs) in China for decades ( Peng et al, 2011 ). Pharmacological studies have revealed that XKST can effectively regulate the abnormal changes in blood lipid and lipid peroxide and have a protective effect on myocardial ischemia and reperfusion injury in animal models ( Liu et al, 2014a ; Liu et al, 2014b ; Yang et al, 2018 ). However, up to now, the quality-control index of XKST is only limited to a few index ingredients in Chinese Pharmacopoeia, which cannot reflect the characteristics of overall pharmacological effects through multi-components of TCM prescription, and there is only little literature available for the holistic quality identification of XKST ( Peng et al, 2011 ; Wang et al, 2012 ; Qing et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%